Douglas L. Jennings - Concepedia

Author

Douglas L. Jennings

Columbia University Irving Medical Center ORCID

Also Known As

D Jennings, D. Jennings, D. L. Jennings, D.L. Jennings, DOUGLAS L. JENNINGS, Douglas J. Jennings, Douglas Jennings, Douglas L Jennings, Douglas L. Jennings

185

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Columbia University Irving Medical Center Henry Ford Hospital Columbia University New York Hospital Queens NewYork–Presbyterian Hospital

About

Douglas L. Jennings is an author at Columbia University Irving Medical Center specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	970
2	Public Health	3	3	53
3	Health Sciences	2	2	114
4	Engineering	1	1	16
5	Biomedical Engineering	1	1	11

Douglas L. Jennings

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients A. Velleca, M. Shullo, K. Dhital, The Journal of Heart and Lung Transplantation TransplantationHeartlung TransplantCardiovascular DiseaseHeart Transplant RecipientsMedicine	2022	522
Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients David M. Salerno, Douglas L. Jennings, Nicholas W. Lange, American Journal of Transplantation	2022	88
Reversal of dabigatran-induced bleeding with a prothrombin complex concentrate and fresh frozen plasma Lisa E. Dumkow, Johnathan Voss, Michael Peters, American Journal of Health-System Pharmacy ImmunohematologyJournal Article ReversalPharmacotherapyProthrombin Complex ConcentrateThrombosis	2012	67
Dose-dependent association between amiodarone and severe primary graft dysfunction in orthotopic heart transplantation Matthew Wright, Koji Takeda, Christine Mauro, The Journal of Heart and Lung Transplantation Transplantation SurgeryDose-dependent AssociationHeart FailureTransplantationCardiovascular Disease	2017	66
COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era Jessica Hedvat, Nicholas W. Lange, David M. Salerno, American Journal of Transplantation	2022	52
Clinical Outcomes Associated With Chronic Antimicrobial Suppression Therapy in Patients With Continuous‐Flow Left Ventricular Assist Devices Douglas L. Jennings, Rachel M. Chambers, Jeffrey A. Morgan Artificial Organs Heart FailureDevice TherapyCardiopulmonary TransplantationAntimicrobial StewardshipSepsis	2014	47
Desensitizing highly sensitized heart transplant candidates with the combination of belatacept and proteasome inhibition Shudhanshu Alishetti, Maryjane Farr, Douglas L. Jennings, American Journal of Transplantation	2020	45
Heart failure related cardiogenic shock: An ISHLT consensus conference content summary Manreet Kanwar, Filio Billia, Varinder K. Randhawa, The Journal of Heart and Lung Transplantation	2023	42
Preoperative Proteinuria and Reduced Glomerular Filtration Rate Predicts Renal Replacement Therapy in Patients Supported With Continuous-Flow Left Ventricular Assist Devices Veli K. Topkara, Ellie J. Coromilas, A.R. Garan, Circulation Heart Failure	2016	41
Survey of Anticoagulation Practices with the Impella Percutaneous Ventricular Assist Device at High-Volume Centers Brent N. Reed, Robert J. DiDomenico, J. Erin Allender, Journal of Interventional Cardiology	2019	40

Page 1